NCT07160075View on ClinicalTrials.gov

HIV Prevention With PrEP Among People on Opioid Replacement Therapy

PHASE4RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions
HIV - Human Immunodeficiency Virus
Interventions
BEHAVIORAL

Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs

Simultaneous administration of OAT and oral PrEP (direct observed therapy or home supply) at existing pharmacy-based programs

Trial Locations (6)

T2R 0X7

NOT_YET_RECRUITING

Sheldon M Chumir Health Centre, Calgary

S4P 0H7

NOT_YET_RECRUITING

Queen City Wellness Pharmacy, Regina

S7L 0V8

RECRUITING

Mayfair Drugs Pharmacy, Saskatoon

S7M 0Y2

RECRUITING

Pharmasave Riversdale Pharmacy, Saskatoon

S7M 0Z7

RECRUITING

The Medicine Shoppe Pharmacy, Saskatoon

S7M 4R5

RECRUITING

Meadowgreen Pharmacy, Saskatoon

Sponsors

Lead Sponsor

Cara Spence

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Cara Spence

OTHER

NCT07160075 - HIV Prevention With PrEP Among People on Opioid Replacement Therapy | Biotech Hunter | Biotech Hunter